Bio-Techne (TECH) Enterprise Value (2009 - 2026)
Bio-Techne (TECH) posted quarterly Enterprise Value of -$209.8 million for Q1 2026, down 49.16% year-over-year from -$412.7 million in Q1 2025, and down 21.37% quarter-over-quarter from -$172.9 million in Q4 2025.
Bio-Techne (TECH) Enterprise Value (2009 - 2026) Analysis & Trends
Bio-Techne's Enterprise Value history runs 18 years deep, the most recent figure standing at -$209.8 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 49.16% year-over-year to -$209.8 million; the TTM figure through Mar 2026 stood at -$209.8 million (down 49.16% YoY), while the FY2025 annual figure was -$162.2 million, down 6.1% from the prior year.
- Enterprise Value for Q1 2026 stood at -$209.8 million, down from -$172.9 million in the prior quarter.
- The five-year high for Enterprise Value was -$135.7 million in Q4 2023, with the low at -$247.8 million in Q2 2022.
- The 5-year median for Enterprise Value is -$172.9 million (2025), against an average of -$177.6 million.
- The sharpest annual moves came in 2023 and 2026: Enterprise Value surged 32.31% in 2023, then slumped 49.16% in 2026.
- Bio-Techne's Enterprise Value stood at -$196.8 million in 2022, then surged by 31.06% to -$135.7 million in 2023, then plunged by 30.89% to -$177.5 million in 2024, then grew by 2.63% to -$172.9 million in 2025, then slipped by 21.37% to -$209.8 million in 2026.
- Business Quant data shows TECH's Enterprise Value at -$209.8 million in Q1 2026, -$172.9 million in Q4 2025, and -$145.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Bio-Techne | 11.33 Bn | 11.12 Bn | 208.29 Mn | -209.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -209.82 Mn |
| Dec 31, 2025 | -172.88 Mn |
| Sep 30, 2025 | -144.96 Mn |
| Jun 30, 2025 | -162.19 Mn |
| Mar 31, 2025 | -140.67 Mn |
| Dec 31, 2024 | -177.55 Mn |
| Sep 30, 2024 | -187.54 Mn |
| Jun 30, 2024 | -152.86 Mn |
| Mar 31, 2024 | -145.31 Mn |
| Dec 31, 2023 | -135.65 Mn |
| Sep 30, 2023 | -148.66 Mn |
| Jun 30, 2023 | -204.31 Mn |
| Mar 31, 2023 | -157.20 Mn |
| Dec 31, 2022 | -196.76 Mn |
| Sep 30, 2022 | -203.08 Mn |
| Jun 30, 2022 | -247.79 Mn |
| Mar 31, 2022 | -232.23 Mn |
| Dec 31, 2021 | -279.44 Mn |
| Sep 30, 2021 | -227.47 Mn |
| Jun 30, 2021 | -223.29 Mn |